Medicalgorithmics S.A.
MDG.WA · WSE
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.45 | -0.07 | 0.36 | -0.16 |
| FCF Yield | -1.36% | -2.72% | -2.50% | -1.62% |
| EV / EBITDA | -81.52 | -47.71 | -218.07 | -31.20 |
| Quality | ||||
| ROIC | -3.99% | -5.33% | -1.74% | -5.46% |
| Gross Margin | 81.61% | 87.06% | 92.92% | -5.31% |
| Cash Conversion Ratio | 0.01 | 1.24 | 0.11 | 0.31 |
| Growth | ||||
| Revenue 3-Year CAGR | -18.29% | -24.20% | -31.53% | -35.99% |
| Free Cash Flow Growth | 23.18% | 26.48% | -165.54% | 57.77% |
| Safety | ||||
| Net Debt / EBITDA | -0.75 | 0.39 | 2.13 | 1.36 |
| Interest Coverage | -15.69 | -77.53 | -36.96 | -176.66 |
| Efficiency | ||||
| Inventory Turnover | 0.16 | 0.08 | 0.03 | 0.59 |
| Cash Conversion Cycle | 461.79 | 941.96 | 2,160.66 | 224.88 |